Ethanol derived acetate modifies brain epigenetic landscape

Derek Sung: @immunofluorescence

Faculty Spotlight: Cesar de la Fuente

Regenerating the lung: harnessing the untapped potential of AT2 cells

Where are they now – Theonie Anastassiadis

Faculty Spotlight: Will Bailis

1/3
Please reload

November 19, 2019

Runny noses, body aches, and chills – dreaded signs that the flu season is upon us. The cough, however, remains one of the most painful flu symptoms and is a clear indication that the influenza virus has successfully invaded the lungs. Though the lungs provide critical protection from environmental insults, they are also highly susceptible to injury caused by influenza. Fortunately, the lungs have a remarkable ability to regenerate in response to infection and disease. Damage to the lung often results in loss of alveolar type 1 (AT1) cells, which make up the majority of the lung epithelial surface and mediate oxygen and carbon dioxide gas exchange. Regene...

November 19, 2019

Dr. Theonie Anastassiadis, 2017 alumna of CAMB/Cancer Biology, thought she knew what she wanted to do after graduate school. Theonie always pictured herself on the academic track and eventually running her own lab. However, in the summer of 2017, Theonie pursued an opportunity that changed the course of her career by participating as a Summer Fellow at a biotechnology venture creation firm known as Flagship Pioneering in Cambridge, Mass. After her summer at the company, she was offered a full-time position, where she now works as part of an entrepreneurial team to originate, resource, manage and grow bioscience companies that create breakthroughs in healt...

November 19, 2019

A person is diagnosed with a blood cancer in the United States every 3 minutes. In 2019, blood cancer is expected to make up 10% of all new cancer cases diagnosed in the country. While chemotherapy remains the standard of care for blood cancer patients, hematopoietic stem cell transplant (also called bone marrow transplant) has improved the survival rate for some of these cancers from 0% to nearly 80%. Bone marrow transplant is a complex procedure where the patient’s damaged hematopoietic stem cells are completely removed with radiation and chemotherapy, and replaced with healthy stem cells from a matched bone marrow donor.

Be The Match is a national bone...

August 16, 2019

Dr. Rinho Kim started his Ph.D. in the Fall of 2010 as part of the Genetics and Epigenetics graduate group. He joined Dr. Klaus Kaestner’s lab for his thesis work in studying the epigenetic regulation of intestinal stem cell differentiation. Dr. Kim was always interested in Next-Generation Sequencing (NGS) technologies and started working on developing his wet and dry lab skills in the field early on in his thesis project.

After graduating in the fall of 2016, Dr. Kim wanted to apply his skills to human disease research. He also wanted to explore opportunities in Europe, having spent the previous 8.5 years in the US after moving here from South Korea. He t...

July 3, 2019

Dr. Rachel Leibman graduated from CAMB (Microbiology, Virology, and Parasitology) in 2017 after completing her training in Dr. Jim Riley’s laboratory. After two years in her current position as a Clinical Scientist, she is excited to share her experience with current students, and tell us how CAMB graduates are undoubtedly qualified for this translational-focused field.

Rachel works for Stemcentrx, an oncology biotech startup acquired by AbbVie, a global pharmaceutical company and spin-off of Abbott Laboratories. As a Clinical Scientist, she supports clinical trials and clinical program development. Rachel describes herself as the right-hand woman to the M...

Please reload

Archives
Please reload

Categories
Please reload

Follow CAMB on Twitter
  • Twitter Basic Black
Visitors
This site was designed with the
.com
website builder. Create your website today.
Start Now